111 related articles for article (PubMed ID: 20066827)
1. Peripheral arterial disease: update of overview and treatment.
Schirmang TC; Ahn SH; Murphy TP; Dubel GJ; Soares GM
Med Health R I; 2009 Dec; 92(12):398-402. PubMed ID: 20066827
[No Abstract] [Full Text] [Related]
2. Prevalence and association between risk factors, stroke subtypes, and abnormal ankle brachial index in acute ischemic stroke.
Ratanakorn D; Keandoungchun J; Tegeler CH
J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):498-503. PubMed ID: 21236702
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and treatment patterns of lower extremity peripheral arterial disease among patients at risk in ambulatory health settings.
Makowsky M; McMurtry MS; Elton T; Rosenthal M; Gunther M; Percy M; Wong K; Fok J; Sebastianski M; Tsuyuki R
Can J Cardiol; 2011; 27(3):389.e11-8. PubMed ID: 21601776
[TBL] [Abstract][Full Text] [Related]
4. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association.
Aboyans V; Criqui MH; Abraham P; Allison MA; Creager MA; Diehm C; Fowkes FG; Hiatt WR; Jönsson B; Lacroix P; Marin B; McDermott MM; Norgren L; Pande RL; Preux PM; Stoffers HE; Treat-Jacobson D; ; ; ; ;
Circulation; 2012 Dec; 126(24):2890-909. PubMed ID: 23159553
[No Abstract] [Full Text] [Related]
5. [Newly diagnosed peripheral arterial disease in patients with cardiovascular risk factor].
Brănişteanu R; Datcu MD; Aursulesei V
Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1062-8. PubMed ID: 22276447
[TBL] [Abstract][Full Text] [Related]
6. ABI derived from the highest and lowest ankle pressure. What is the difference?
Kröger K; Bock E; Hohenberger T; Moysidis T; Santosa F; Pfeifer M;
Int Angiol; 2010 Dec; 29(6):482-8. PubMed ID: 21173729
[TBL] [Abstract][Full Text] [Related]
7. Peripheral arterial disease - diagnosis and management in general practice.
Au TB; Golledge J; Walker PJ; Haigh K; Nelson M
Aust Fam Physician; 2013 Jun; 42(6):397-400. PubMed ID: 23781547
[TBL] [Abstract][Full Text] [Related]
8. Impact of lower limbs' arterial calcification on the prevalence and severity of PAD in patients on hemodialysis.
Ohtake T; Oka M; Ikee R; Mochida Y; Ishioka K; Moriya H; Hidaka S; Kobayashi S
J Vasc Surg; 2011 Mar; 53(3):676-83. PubMed ID: 21211928
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of asymptomatic and symptomatic peripheral arterial disease and peripheral arterial disease risk factors in the U.S. population.
Aponte J
Holist Nurs Pract; 2011; 25(3):147-61. PubMed ID: 21508715
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
[TBL] [Abstract][Full Text] [Related]
11. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
Shigematsu H; Nishibe T; Obitsu Y; Matsuzaki K; Ishida A; Miyata T; Shindo S; Hida K; Ohta T; Ando M; Kawasaki T; Yasugi T; Matsumoto T
Int Angiol; 2010 Apr; 29(2 Suppl):2-13. PubMed ID: 20357743
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based score to detect prevalent peripheral artery disease (PAD).
Duval S; Massaro JM; Jaff MR; Boden WE; Alberts MJ; Califf RM; Eagle KA; D'Agostino RB; Pedley A; Fonarow GC; Murabito JM; Steg PG; Bhatt DL; Hirsch AT;
Vasc Med; 2012 Oct; 17(5):342-51. PubMed ID: 22711750
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of peripheral arterial disease in patients with heart failure by race and ethnicity.
Hebert K; Lopez B; Michael C; Franco E; Dias A; Trahan P; Huang S; Tamariz L; Arcement L
Congest Heart Fail; 2010; 16(3):118-21. PubMed ID: 20557331
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol does not improve peripheral arterial disease-linked oxidative stress.
Bernal-Lopez MR; Peña D; Gomez-Martin P; Tinahones FJ; Gomez-Huelgas R
Cardiovasc Ther; 2015 Feb; 33(1):15-9. PubMed ID: 25393963
[TBL] [Abstract][Full Text] [Related]
15. Summaries for patients: screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med; 2013 Sep; 159(5):I-28. PubMed ID: 24026333
[No Abstract] [Full Text] [Related]
16. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
[TBL] [Abstract][Full Text] [Related]
17. Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study.
Lim PS; Jeng Y; Wu MY; Pai MA; Wu TK; Chen CH
Biomed Res Int; 2016; 2016():8236903. PubMed ID: 27747241
[No Abstract] [Full Text] [Related]
18. [Prevalence of an abnormal ankle-brachial index in the Republic of Tatarstan].
Maksimov AV; Gaĭsina ÉA; Plotnikov MV; Nuretdinov RM; Feĭskhanov AK
Angiol Sosud Khir; 2012; 18(4):28-30. PubMed ID: 23324631
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus.
Rhee SY; Kim YS; Chon S; Oh S; Woo JT; Kim SW; Kim JW
Diabetes Res Clin Pract; 2011 Jan; 91(1):e11-4. PubMed ID: 20934769
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of peripheral arterial disease in hypertensive patients: the Evaluation of Ankle-Brachial Index in Hungarian Hypertensives screening program.
Farkas K; Járai Z; Kolossváry E; Ludányi A; Clement DL; Kiss I;
J Hypertens; 2012 Aug; 30(8):1526-32. PubMed ID: 22743684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
